ovaries removed before age 45 and who never used hormone replacement therapy had a lower bone mineral density in their neck bones, compared to those who still had their ovaries. Women who had undergone oophorectomy were also more likely to develop osteoporosis.
What's more, women with both ovaries removed had a higher risk of arthritis, especially if they never used hormone replacement therapy.
More than 45 percent of women who had oophorectomy reported being diagnosed with arthritis, compared to 32.1 percent of women with their ovaries still intact.
Doctors need to be aware of these potential risks so they can intervene if needed, says McCarthy.
"[The study] highlights the need for more research in this area to identify those women at risk and to determine appropriate screening preventive strategies for these young women," she concludes.
For their cross-sectional study, McCarthy and Dr. Visvanathan examined data from the Third National Health and Nutrition Examination Survey (NHANES III). For the bone mineral density portion of their study, they looked at data from 3,660 women. The arthritis portion of the study used data from 4,039 women.
The study's results were presented at the 2011 San Antonio Breast Cancer Symposium, sponsored by the Cancer Therapy & Research Center at the University of Texas Health Science Center at San Antonio, the American Association for Cancer Research, and Baylor College of Medicine.
Ovarian Cancer Research Fund hands out grants January 04, 2012 Grants and Giving News A number of different medical institutions recently got added funding thanks to grants from a New York-based charity.
Ovarian Cancer Research Fund said in a statement that it would be donating a total of $5.4 million, through grants ranging from $75,000 to $900,000 to research teams to help fund projects. The institutions getting money included MD Anderson
Cancer Center, Johns Hopkins University School of Medicine. Baylor College of Medicine, Brigham and Women's Hospital and Cedars-Sinai Medical Center,
"This research is a recognition that ovarian cancer should not be treated similarly in all cases," said Jeff Boyd, chair of the foundation's scientific advisory committee. "And, as we gain a better understanding of the origins of this extraordinary complex disease, this may inspire a rebirth and a new wave of research into much-needed screening and early detection methods."
Late last year other organizations made news after donating money to cancer research. The University of Texas MD Anderson Cancer Center received $500 million from T. Boone Pickens as part of its nonprofit fundraising effort.
http://www.sagefundraising.com/Products
Sharing experiences: Ovarian cancer Stories from around the globe
Wendy Williams’ mum Ann Lack was one of many women not diagnosed until the disease was in its later stages and died within months.
Now Mrs Williams wants to raise awareness of the disease which is the fourth most common cause of cancer deaths in women in the country.
More than 6,600 women are diagnosed with ovarian cancer every year in the UK and 4,400 will die, with 75 per cent of them not diagnosed until the later stages when little can be done.
Mrs Williams, 51, of Rayns Close, Sprowston, said: “Mum didn’t know anything about ovarian cancer. It’s called the silent killer and had she known more about the symptoms, she would have been more aware.
Feel Teal Club©2012 21
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49